Cargando...

Characteristics and outcomes of patients with V299L BCR-ABL kinase domain mutation after therapy with tyrosine kinase inhibitors

Gardado en:
Detalles Bibliográficos
Main Authors: Jabbour, Elias, Morris, Van, Kantarjian, Hagop, Yin, Cameron C., Burton, Elizabeth, Cortes, Jorge
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Hematology 2012
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4195445/
https://ncbi.nlm.nih.gov/pubmed/23086624
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-04-424192
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!